Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production. [electronic resource]

By: Contributor(s): Producer: 20121002Description: e39 p. digitalISSN:
  • 2044-5385
Online resources: In: Blood cancer journal vol. 1
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.